Show
Sort by
-
Evaluation of targeted drugs in combination with the MDM2 antagonist RG7388 in neuroblastoma
-
Targeted analysis of TP53 pathway SNPs in neuroblastoma patients
-
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients
-
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients
-
- Journal Article
- A1
- open access
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients
-
Characterization of ALK driven molecular networks identifies perturbed RET and cholinergic signaling in neuroblastoma
-
Genetisch geïnspireerde toekomstperspectieven voor de therapie van het neuroblastoom
-
The HBP1 tumor suppressor is a druggable ALK downregulated gene controlling MYCN activity
-
The HBP1 tumor suppressor is a druggable ALK downregulated gene controlling MYCN activity
-
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma